97 related articles for article (PubMed ID: 1960449)
1. [In vitro and clinical study of complement activation during cardiopulmonary bypass with reference to types of oxygenator, primed autologous blood and patient's factor].
Oda K
Nihon Kyobu Geka Gakkai Zasshi; 1991 Sep; 39(9):1703-11. PubMed ID: 1960449
[TBL] [Abstract][Full Text] [Related]
2. Significance of the concentrated red cell and albumin priming method with particular reference to anaphylatoxin generation.
Tamiya T; Maeo Y; Okada T; Ogoshi S; Fujimoto S; Yasui H
J Thorac Cardiovasc Surg; 1992 Jan; 103(1):78-86. PubMed ID: 1728718
[TBL] [Abstract][Full Text] [Related]
3. [A study on complement activation in cardiopulmonary bypass--experimental and clinical evaluations].
Yamasaki M
Nihon Kyobu Geka Gakkai Zasshi; 1989 Feb; 37(2):234-41. PubMed ID: 2788676
[TBL] [Abstract][Full Text] [Related]
4. [Improvement of extracorporeal circulation on the basis of anaphylatoxin levels, with special reference to oxygenation mechanisms and plasma denaturation by oxygen bubbling].
Maeo Y
Nihon Kyobu Geka Gakkai Zasshi; 1989 Oct; 37(10):2166-74. PubMed ID: 2584778
[TBL] [Abstract][Full Text] [Related]
5. Complement activation in cardiopulmonary bypass, with special reference to anaphylatoxin production in membrane and bubble oxygenators.
Tamiya T; Yamasaki M; Maeo Y; Yamashiro T; Ogoshi S; Fujimoto S
Ann Thorac Surg; 1988 Jul; 46(1):47-57. PubMed ID: 3382287
[TBL] [Abstract][Full Text] [Related]
6. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
Cavarocchi NC; Pluth JR; Schaff HV; Orszulak TA; Homburger HA; Solis E; Kaye MP; Clancy MS; Kolff J; Deeb GM
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):252-8. PubMed ID: 3511328
[TBL] [Abstract][Full Text] [Related]
7. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation.
van Oeveren W; Kazatchkine MD; Descamps-Latscha B; Maillet F; Fischer E; Carpentier A; Wildevuur CR
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):888-99. PubMed ID: 3158783
[TBL] [Abstract][Full Text] [Related]
8. [Fundamental and clinical studies of homologous immunoglobulin-free priming in cardiopulmonary bypass, with special reference to anaphylatoxin production].
Okada T; Maeo Y; Oda K
Nihon Geka Gakkai Zasshi; 1992 Feb; 93(2):189-96. PubMed ID: 1552891
[TBL] [Abstract][Full Text] [Related]
9. Different oxygenators for cardiopulmonary bypass lead to varying degrees of human complement activation in vitro.
Videm V; Fosse E; Mollnes TE; Ellingsen O; Pedersen T; Karlsen H
J Thorac Cardiovasc Surg; 1989 May; 97(5):764-70. PubMed ID: 2709867
[TBL] [Abstract][Full Text] [Related]
10. Clinical study of blood trauma during perfusion with membrane and bubble oxygenators.
van den Dungen JJ; Karliczek GF; Brenken U; Homan van der Heide JN; Wildevuur CR
J Thorac Cardiovasc Surg; 1982 Jan; 83(1):108-16. PubMed ID: 7054605
[TBL] [Abstract][Full Text] [Related]
11. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
[TBL] [Abstract][Full Text] [Related]
12. Effect of polymer coating (poly 2-methoxyethylacrylate) of the oxygenator on hemostatic markers during cardiopulmonary bypass in children.
Eisses MJ; Geiduschek JM; Jonmarker C; Cohen GA; Chandler WL
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):28-34. PubMed ID: 17289476
[TBL] [Abstract][Full Text] [Related]
13. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
[TBL] [Abstract][Full Text] [Related]
14. The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
Senay S; Toraman F; Gunaydin S; Kilercik M; Karabulut H; Alhan C
Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):93-9. PubMed ID: 18801802
[TBL] [Abstract][Full Text] [Related]
15. Improved biocompatibility of extracorporeal circulation by the use of auto-oxygenation instead of artificial oxygenator in perfusion circuit.
Bochenek A; Religa Z; Kustosz R; Wnuk-Wojnar AM; Wnuk R; Wojnar J; Woś S; Wites M; Zembala M; Spyt T
Nephrol Dial Transplant; 1991; 6 Suppl 3():75-80. PubMed ID: 1775272
[TBL] [Abstract][Full Text] [Related]
16. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.
Videm V; Svennevig JL; Fosse E; Semb G; Osterud A; Mollnes TE
J Thorac Cardiovasc Surg; 1992 Apr; 103(4):806-13. PubMed ID: 1548925
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of Duraflo II heparin-coated circuits on postperfusion lung dysfunction.
Ranucci M; Cirri S; Conti D; Ditta A; Boncilli A; Frigiola A; Menicanti L
Ann Thorac Surg; 1996 Jan; 61(1):76-81. PubMed ID: 8561642
[TBL] [Abstract][Full Text] [Related]
18. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
Cavarocchi NC; Schaff HV; Orszulak TA; Homburger HA; Schnell WA; Pluth JR
Surgery; 1985 Sep; 98(3):525-31. PubMed ID: 3875906
[TBL] [Abstract][Full Text] [Related]
19. [Effects of blood washing and autotransfusion during cardiopulmonary bypass on erythrocyte immune and kidney function].
Song Y; Li R; Gu XH; Gong XJ; Zhang G; Wu SM; Zhang XQ; Li SX
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2293-6. PubMed ID: 17064580
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bubble and membrane oxygenators in short and long perfusions.
Clark RE; Beauchamp RA; Magrath RA; Brooks JD; Ferguson TB; Weldon CS
J Thorac Cardiovasc Surg; 1979 Nov; 78(5):655-66. PubMed ID: 491720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
